pmid,title,journal,year,drug,disease
39407035,Ischemic stroke as a presenting feature of promyelocytic blast phase in chronic myeloid leukemia - an uncommon presentation: a case report and literature review in the post imatinib era.,Annals of hematology,2024,Dasatinib,Ischemic Stroke
39084350,Exosomal Src from hypoxic vascular smooth muscle cells exacerbates ischemic brain injury by promoting M1 microglial polarization.,Neurochemistry international,2024,Dasatinib,Ischemic Stroke
37354090,Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.,Cancer,2023,Dasatinib,Ischemic Stroke
35530837,Dasatinib-Induced Bilateral Pleural Effusions.,Cureus,2022,Dasatinib,Ischemic Stroke
35343478,[Cardiovascular management of patients with chronic myeloid leukemia treated with BCR-ABL tyrosine kinase inhibitors: it is time for a shared management].,Giornale italiano di cardiologia (2006),2022,Dasatinib,Ischemic Stroke
30797908,Dasatinib Reinitiation After Poststroke Thrombolysis Associated with Symptomatic Intracerebral Hemorrhage.,World neurosurgery,2019,Dasatinib,Ischemic Stroke
29165288,Treatment-Related Noncontiguous Radiologic Changes in Children With Diffuse Intrinsic Pontine Glioma Treated With Expanded Irradiation Fields and Antiangiogenic Therapy.,"International journal of radiation oncology, biology, physics",2017,Dasatinib,Ischemic Stroke
28890835,Ponatinib as a Valid Alternative Strategy in Patients with Blast Crisis-Chronic Myeloid Leukemia Not Eligible for Allogeneic Stem Cells Transplantation and/or Conventional Chemotherapy: Report of a Case.,Case reports in hematology,2017,Dasatinib,Ischemic Stroke
26630962,Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?,Current neuropharmacology,2015,Dasatinib,Ischemic Stroke
